Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

Mar 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The End of Silicon Valley as We Know It?

Sep 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Federated learning for predicting clinical outcomes in patients with COVID-19

Sep 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

How AI simplifies data management for drug discovery

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Reportable Launches Media Monitoring Service for Biotech, Medical Device and Pharmaceutical Companies

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

UK life science attracts £850m deal

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

UK life science attracts £850m deal

Apr 6
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

How Artificial Intelligence is Transforming the Healthcare Industry

Jan 26
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Globalization and Democratization of Innovation

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Morocco’s Mohammed VI Polytechnic University and ALPHA10X Sign Research and Development Partnership Agreement

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X